Cargando…

Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus

Rhinoviruses are the pathogens most often responsible for the common cold, and are a frequent cause of exacerbations in asthma, chronic obstructive pulmonary disease and cystic fibrosis. Here we report discovery of IMP-1088, a picomolar dual inhibitor of the human N-myristoyltransferases NMT1 and NM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mousnier, Aurélie, Bell, Andrew S., Swieboda, Dawid P., Morales-Sanfrutos, Julia, Pérez-Dorado, Inmaculada, Brannigan, James A., Newman, Joseph, Ritzefeld, Markus, Hutton, Jennie A., Guedán, Anabel, Asfor, Amin A., Robinson, Sean W., Hopkins-Navratilova, Iva, Wilkinson, Anthony J., Johnston, Sebastian L., Leatherbarrow, Robin J., Tuthill, Tobias J., Solari, Roberto, Tate, Edward W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015761/ https://www.ncbi.nlm.nih.gov/pubmed/29760414 http://dx.doi.org/10.1038/s41557-018-0039-2

Ejemplares similares

Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication
por: Guedán, Anabel, et al.
Publicado: (2017)

Novel Thienopyrimidine Inhibitors of Leishmania N-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes
por: Bell, Andrew S., et al.
Publicado: (2020)

Whole Proteome Profiling of N-Myristoyltransferase Activity and Inhibition Using Sortase A
por: Goya Grocin, Andrea, et al.
Publicado: (2019)

Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors
por: Brannigan, James A., et al.
Publicado: (2014)

Structure-Based Design of Potent and Selective LeishmaniaN-Myristoyltransferase Inhibitors
por: Hutton, Jennie A., et al.
Publicado: (2014)

Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites
por: Olaleye, Tayo O., et al.
Publicado: (2014)

Human Rhinovirus 16 Causes Golgi Apparatus Fragmentation without Blocking Protein Secretion
por: Mousnier, Aurelie, et al.
Publicado: (2014)

Structure-guided optimization of quinoline inhibitors of Plasmodium N-myristoyltransferase
por: Goncalves, Victor, et al.
Publicado: (2016)

Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase
por: Yu, Zhiyong, et al.
Publicado: (2015)

Discovery of Novel and Ligand-Efficient Inhibitors of Plasmodium falciparum and Plasmodium vivaxN-Myristoyltransferase
por: Rackham, Mark D., et al.
Publicado: (2012)

Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase
por: Rackham, Mark D., et al.
Publicado: (2015)

Design and Synthesis of High Affinity Inhibitors of Plasmodium falciparum and Plasmodium vivax N-Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP)
por: Rackham, Mark D., et al.
Publicado: (2014)

Selective Inhibitors of Protozoan Protein N-myristoyltransferases as Starting Points for Tropical Disease Medicinal Chemistry Programs
por: Bell, Andrew S., et al.
Publicado: (2012)

N-Myristoyltransferase Inhibition Induces ER-Stress, Cell Cycle Arrest, and Apoptosis in Cancer Cells
por: Thinon, Emmanuelle, et al.
Publicado: (2016)

High-resolution snapshots of human N-myristoyltransferase in action illuminate a mechanism promoting N-terminal Lys and Gly myristoylation
por: Dian, Cyril, et al.
Publicado: (2020)

N-Myristoyltransferase from Leishmania donovani: Structural and Functional Characterisation of a Potential Drug Target for Visceral Leishmaniasis
por: Brannigan, James A., et al.
Publicado: (2010)

The Cellular Chaperone Heat Shock Protein 90 Is Required for Foot-and-Mouth Disease Virus Capsid Precursor Processing and Assembly of Capsid Pentamers
por: Newman, Joseph, et al.
Publicado: (2018)

The conserved N-terminus of human rhinovirus capsid protein VP4 contains membrane pore-forming activity and is a target for neutralizing antibodies
por: Panjwani, Anusha, et al.
Publicado: (2016)

The Role of Capsid in HIV-1 Nuclear Entry
por: Guedán, Anabel, et al.
Publicado: (2021)

Detection of Bovine Antibodies against a Conserved Capsid Epitope as the Basis of a Novel Universal Serological Test for Foot-and-Mouth Disease
por: Asfor, A. S., et al.
Publicado: (2020)

HIV-1 requires capsid remodelling at the nuclear pore for nuclear entry and integration
por: Guedán, Anabel, et al.
Publicado: (2021)

Structures of foot and mouth disease virus pentamers: Insight into capsid dissociation and unexpected pentamer reassociation
por: Malik, Nayab, et al.
Publicado: (2017)

Validation and Invalidation of Chemical Probes for the Human N-myristoyltransferases
por: Kallemeijn, Wouter W., et al.
Publicado: (2019)

N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness
por: Frearson, Julie A., et al.
Publicado: (2010)

Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists
por: Ajram, Laura, et al.
Publicado: (2014)

Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors
por: Schlott, Anja C., et al.
Publicado: (2019)

Using a Non-Image-Based Medium-Throughput Assay for Screening Compounds Targeting N-myristoylation in Intracellular Leishmania Amastigotes
por: Paape, Daniel, et al.
Publicado: (2014)

Wheat pathogen Zymoseptoria tritici N-myristoyltransferase inhibitors: on-target antifungal activity and an unusual metabolic defense mechanism
por: Fedoryshchak, Roman O., et al.
Publicado: (2020)

Biochemical and genetic characterization of Trypanosoma cruzi N-myristoyltransferase
por: Roberts, Adam J., et al.
Publicado: (2014)

Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry
por: Priyamvada, Lalita, et al.
Publicado: (2022)

The role of N-myristoyltransferase 1 in tumour development
por: Wang, Hong, et al.
Publicado: (2023)

N-Myristoyltransferase Is a Cell Wall Target in Aspergillus fumigatus
por: Fang, Wenxia, et al.
Publicado: (2015)

Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors
por: Bayliss, Tracy, et al.
Publicado: (2017)

Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus
por: Asfor, Amin S., et al.
Publicado: (2014)

QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
por: Santos-Garcia, Letícia, et al.
Publicado: (2018)

Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
por: Corpas-Lopez, Victoriano, et al.
Publicado: (2018)

Identification and structure solution of fragment hits against kinetoplastid N-myristoyltransferase
por: Robinson, David A., et al.
Publicado: (2015)

Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
por: Brand, Stephen, et al.
Publicado: (2011)

Global Analysis of Protein N-Myristoylation and Exploration of N-Myristoyltransferase as a Drug Target in the Neglected Human Pathogen Leishmania donovani
por: Wright, Megan H., et al.
Publicado: (2015)

Inhibition of N‐myristoyltransferase1 affects dengue virus replication
por: Suwanmanee, San, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hvaaluseacqviu36010lbuc0cr